Yogesh Patel
0000-0002-8916-5228
1 paper found
Refreshing results…
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria
Missing publications? Search for publications with a matching author name.